Caribou Biosciences (CRBU) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Caribou Biosciences (CRBU) Company Statistics | The Fly

Caribou Biosciences

· CRBU

Dashboard

Financials

Ratios

Valuation

Statistics

132.937 M

+2.42%

General

Market Cap: $132.94M
Enterprise Value: $126.42M
Shares Outstanding: 99,180,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -129.70%
Operating Margin: -1090.90%
Net Profit Margin: -1030.42%
FCF Margin: -954.18%
ROA: -72.42%
ROE: -89.11%
ROIC: -86.30%
Current Ratio: 6.49
Debt-to-Equity: 0.27
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 12.55
P/FCF: —
P/B: 1.28
EV/EBITDA: -1.21

Growth

Rev 1Y: 11.66%
Rev 1Y Fwd Est: -4.14%
Rev 3Y (CAGR): -6.95%
Rev 5Y (CAGR): -2.03%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $10.04M
Gross Margin: -129.70%
Operating Expenses: $96.46M
Operating Income: -$109.47M
Net Profit: -$103.4M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $26.19M
Working Capital: $98.62M
Total Assets: $142.77M
Net Debt: $461K
Total Liabilities: $44.67M
Total Equity: $98.1M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$95.78M
Cash Flow from Investing: $71.75M
Cash Flow from Financing: $24.98M
Free Cash Flow: -$95.75M
Capital Expenditures: -$28K